Drug Approval | January 21, 2022
Medicines Patent Pool finalises 27 generic manufacturers to produce molnupiravir
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
HTL will build, validate and operate a botulinum manufacturing facility in the US
The data should be submitted by August 12th 2021
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
The country has constantly worked with the spirit of public-private partnership
WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
Subscribe To Our Newsletter & Stay Updated
